Alemtuzumab: Durable Efficacy at 6 Years in MS Alemtuzumab: Durable Efficacy at 6 Years in MS

Extension studies confirm durability of the drug ' s effects in patients with active relapsing-remitting multiple sclerosis, but safety is still an issue.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news